Neutraceuticals in Male Infertility
PM Gopinath1* and Sahityalakshmi Manoharan2
1 Consultant Gynaecologist, JP Surgical Hospital, Ambala City, India
2Consultant Gynaecologist, Civil Hospital, Panchkula, India
*Corresponding Author: PM Gopinath, Director of Reproductive Medicine,
Kauvery Hospital, Vadapalani, Chennai, Tamilnadu, India.
Received:
December 27, 2024; Published: December 31, 2024
Abstract
In about 50% of infertility issues, males are responsible. Quality of semen has deteriorated by 50% to 60% over the last 40 years [1].
Neutraceuticals are food ingredients that provide health benefits including prevention and treatment of disease [2]. Most neutraceu
ticals have antioxidant properties which can help to increase sperm count and improve sperm function.
Keywords: Male Infertility; Semen Quality; Neutraceuticals; Antioxidants
References
- Agarwal A., et al. “A unique view on male infertility around the globe”. Reproductive Biology and Endocrinology 13 (2015): 37.
- Brower V. “Nutraceuticals: poised for a healthy slice of the healthcare market?” Nature Biotechnology 16 (1998): 728-731.
- Schowell MG., et al. “Antioxidants for male subfertility”. Cochrane Database System Review 12 (2014): CD007411.
- Ricci E., et al. “Dietary habits and semen parameters: A systematic narrative review”. Andrology 6 (2018): 104-116.
- Kefer JC., et al. “Role of antioxidants in the treatment of male infertility”. International Journal of Urology 16 (2009): 449-457.
- Agarwal A., et al. “Role of reactive oxygen species in the pathophysiology of human reproduction”. Fertility and Sterility 79 (2003): 829-843.
- Ryan TC., et al. “Measurement of superoxide release in the phagovacuoles of immune complex-stimulated human neutrophils”. Journal of Immunology Methods 130 (1990): 223-233.
- Kao SH., et al. “Increase in oxidative stress in human sperm with lower motility”. Fertility and Sterility 89 (2008): 1183-90
- Agarwal A., et al. “Clinical evidence of oxidative stress in patients with male factor infertility: evidence-based analysis”. AUA Update Ser 26 (2007): 1-12.
- Martin-Hidalgo D., et al. “Antioxidants and male fertility: From molecular studies to clinical evidence”. Antioxidants 8 (2019): 89.
- Tanimura J. “Studies on arginine in human semen. Part II. The effects of medication with Larginine HCl on male infertility”. Bulletin of the Osaka Medical School 13 (1967): 84-89.
- Schachter A., et al. “Treatment of oligospermia with the amino acid arginine”. Journal of Urology 110 (1973): 311-313.
- De Aloysio D., et al. “The clinical use of arginine aspartate in male infertility”. Acta Europaea fertilitatis 13 (1982): 133-167.
- Miroueh A. “Effect of arginine on oligospermia”. Fertility and Sterility 21 (1970): 217-9.
- Pryor JP., et al. “Controlled clinical trial of arginine for infertile men with oligozoospermia”. British Journal of Urology 50 (1978): 47-50.
- Prasad AS. “Zinc in human health: effect of zinc on immune cells”. Molecular Medicine 14 (2008): 353-357.
- Kothari RP. “Zinc levels in seminal fluid in infertile males and its relation with serum free testosterone”. JCDR 10 (2016): CC05-CC08.
- Gammoh NZ and Rink L. “Zinc in infection and inflammation”. Nutrients 9 (2017): 624.
- Hidaka T., et al. “Safety assessment of coenzyme Q10 (CoQ10)”. Biofactors 32 (2008): 199-208.
- Littarru GP and Tiano L. “Clinical aspects of coenzyme Q10: an update”. Nutrition 26 (2010): 250-254.
- Wallace E., et al. “Functional and developmental studies on the role of selenium in spermatogenesis”. In: Coombs GF Jr., et al. “Selenium in biology and medicine. Pt A. New York: Van Nostrand Reinhold (1987): 181-96.
- Ursini F., et al. “Dual function of the selenoprotein PHGPx during sperm maturation”. Science 285 (1992): 1393-1396.
- Burton GW and Traber MG. “Vitamin E: antioxidant activity, biokinetics, and bioavailability”. Annual Review of Nutrition 10 (1990): 357-382.
- Ebisch IM., et al. “The importance of folate, zinc and antioxidants in the pathogenesis and prevention of subfertility”. Human Reproduction Update 13 (2007): 163-174.
- Lenzi A., et al. “Glutathione therapy for male infertility”. Archives of Andrology 29 (1992): 65-68.
- Lenzi A., et al. “Glutathione treatment of dyspermia: effect on the lipoperoxidation process”. Human Reproduction 9 (1994): 2044-2050.
- Safarinejad MR., et al. “Relationship of omega-3 and omega-6 fatty acids with semen characteristics, and anti-oxidant status of seminal plasma: a comparison between fertile and infertile men”. Clinical Nutrition 29 (2010): 100-105.
- Safarinejad MR. “Effect of omega-3 polyunsaturated fatty acid supplementation on semen profile and enzymatic anti-oxidant capacity of seminal plasma in infertile men with idiopathic oligoasthenoteratospermia: a double-blind, placebo-controlled, randomised study”. Andrologia 43 (2011): 38-47.
- Agarwal A., et al. “Lycopene and male infertility”. Asian Journal of Andrology 16 (2014): 420.
- Gupta NP and Kumar R. “Lycopene therapy in idiopathic male infertility—a preliminary report”. International Urology and Nephrology 34 (2002): 369-372.
- Chung SS and Wolgemuth DJ. “Role of retinoid signaling in the regulation of spermatogenesis”. Cytogenetic Genome Research 105 (2004): 189-202.
- Kamal-Eldin A and Appelqvist LA. “The chemistry and antioxidant properties of tocopherols and tocotrienols”. Lipids 31 (1996): 671-701.
- Dawson EB., et al. “Effect of ascorbic acid on male fertility”. Annals of the New York Academy of Sciences 498 (1987): 312-323.
- Colagar AH., et al. “Ascorbic acid in human seminal plasma: determination and its relationship to sperm quality”. Journal of Clinical Biochemistry and Nutrition 45 (2009): 144-149.
- Palamanda JR and Kehrer JR. “Involvement of vitamin E and protein thiols in the inhibition of microsomal lipid peroxidation by glutathione”. Lipids 23 (1993): 427-443.
- Suleiman SA., et al. “Lipid peroxidation and human sperm motility: protective role of vitamin E”. J Journal of Andrology 17 (1996): 530-537.
Citation
Copyright